Article ID Journal Published Year Pages File Type
5594568 American Heart Journal 2017 22 Pages PDF
Abstract
The REDEFINE trial will study the effects of RAAS inhibition with losartan in TOF patients with RV dysfunction.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Right vEntricular Dysfunction in tEtralogy of Fallot: INhibition of the rEnin-angiotensin-aldosterone system (REDEFINE) trial: Rationale and design of a randomized, double-blind, placebo-controlled clinical trial
Authors
, , , , , , , , , , , , , , , , , , , ,